Option chain shows key data for Medigene's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Medigene.

Medigene (OTC:MDGEF) Stock, Option Chain

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Analyst Color

Biotech

Long Ideas

News

Health Care

Reiteration

Exclusives

Analyst Ratings

Trading Ideas

Interview

General

BLUE

MDGEF

PowerShares ETF Trust Dynamic Biotech & Genome Port

SBIO

Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy

Rumors

Movers

AMGN

Benzinga&#39;s M&amp;A Chatter for Monday December 21, 2015

Medigene AG

Medigene AG reports FY results

Medigene AG (MDGEF) Full Year 2023 Earnings Call Transcript

Medigene AG 2023 Q4 - Results - Earnings Call Presentation

Medigene AG reports Q1 results

Medigene AG reports H1 results

Medigene AG (MDGEF) Q2 2024 Earnings Call Transcript

Medigene AG reports Q3 results

CureVac names former Cardior CFO Axel Sven Malkomes as new CFO

CVAC

Medigene

Comments

Medigene

Medigene (MDGEF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga